JHS Svendgaard Laboratories Ltd

JHS Svendgaard Laboratories Ltd

₹ 17.5 -1.96%
19 Apr 1:35 p.m.
About

Incorporated in 1997, JHS Svendgaard Laboratories Ltd does manufacturing of
oral and dental products for national and international brands[1]

Key Points

Business Overview:[1]
JHSSLL manufactures Toothbrushes, Toothpastes, Mouthwash and Denture Tablets. Apart from working on its own brands viz. Dr. Gold, Aquawhite, etc. company also offers Contract Manufacturing Partnership to brands in domestic and international markets

  • Market Cap 137 Cr.
  • Current Price 17.5
  • High / Low 39.5 / 14.5
  • Stock P/E 28.2
  • Book Value 21.8
  • Dividend Yield 0.00 %
  • ROCE -1.08 %
  • ROE 0.95 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.81 times its book value
  • Debtor days have improved from 123 to 78.4 days.
  • Company's working capital requirements have reduced from 182 days to 47.2 days

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -7.27% over past five years.
  • Promoter holding is low: 37.7%
  • Company has a low return on equity of -0.12% over last 3 years.
  • Company's cost of borrowing seems high
  • Promoter holding has decreased over last 3 years: -4.04%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Personal Care - Indian

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
26.94 25.38 21.59 24.64 20.91 19.11 21.31 21.05 22.19 25.40 15.90 18.93 14.30
25.12 25.33 22.29 23.50 22.05 19.25 22.77 23.02 24.41 28.25 18.02 18.52 14.36
Operating Profit 1.82 0.05 -0.70 1.14 -1.14 -0.14 -1.46 -1.97 -2.22 -2.85 -2.12 0.41 -0.06
OPM % 6.76% 0.20% -3.24% 4.63% -5.45% -0.73% -6.85% -9.36% -10.00% -11.22% -13.33% 2.17% -0.42%
0.76 4.39 2.58 1.69 2.74 2.38 1.48 2.52 0.94 -10.82 0.41 0.20 2.34
Interest 0.30 0.31 0.24 0.27 0.27 0.61 0.68 0.12 0.16 0.39 0.13 0.10 0.11
Depreciation 1.84 1.62 1.79 1.86 1.71 1.69 1.70 1.49 1.46 2.31 1.32 1.50 1.63
Profit before tax 0.44 2.51 -0.15 0.70 -0.38 -0.06 -2.36 -1.06 -2.90 -16.37 -3.16 -0.99 0.54
Tax % 75.00% -13.15% -80.00% 34.29% 92.11% -7,300.00% -75.85% 13.21% 4.83% 38.12% 18.35% 26.26% 100.00%
0.11 2.85 -0.29 0.47 -0.02 -4.44 -4.16 -0.92 -2.76 -10.12 -2.59 -0.73 0.01
EPS in Rs 0.02 0.41 -0.04 0.04 0.04 -0.67 -0.59 -0.14 -0.43 -1.52 -0.40 -0.09 0.00
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
127 60 35 55 100 104 140 124 139 101 86 96 75
110 48 39 59 93 92 126 124 137 99 87 105 79
Operating Profit 16 12 -4 -4 7 12 14 0 2 2 -1 -9 -5
OPM % 13% 20% -11% -7% 7% 11% 10% 0% 1% 2% -1% -9% -6%
1 12 -3 -6 -17 0 32 6 3 7 9 -4 -8
Interest 6 10 14 0 0 1 1 1 2 1 1 1 1
Depreciation 7 14 15 12 10 6 7 7 9 7 7 7 7
Profit before tax 3 0 -35 -22 -22 5 38 -2 -6 1 0 -22 -20
Tax % 66% 1,357% 18% -0% 0% -327% 32% 19% 17% -39% 4,000% 23%
1 -4 -29 -22 -22 22 26 -2 -5 1 -4 -17 -13
EPS in Rs 0.63 -1.56 -11.95 -9.20 -5.76 4.98 4.29 -0.11 -0.33 0.19 -0.62 -2.38 -2.01
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 5%
5 Years: -7%
3 Years: -12%
TTM: -11%
Compounded Profit Growth
10 Years: 8%
5 Years: -26%
3 Years: 2%
TTM: 141%
Stock Price CAGR
10 Years: 10%
5 Years: -7%
3 Years: -2%
1 Year: 2%
Return on Equity
10 Years: -1%
5 Years: 0%
3 Years: 0%
Last Year: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 18 24 24 24 38 44 61 61 61 64 65 65 78
Reserves 97 65 38 96 57 86 113 116 117 124 121 108 92
67 101 54 19 3 2 2 7 9 7 6 3 2
52 41 74 33 25 23 32 39 55 33 30 60 24
Total Liabilities 233 232 190 171 122 155 208 223 241 228 222 236 197
52 135 121 108 65 65 71 71 66 63 59 66 69
CWIP 24 0 0 0 1 1 1 5 7 9 20 9 5
Investments 0 0 0 0 0 1 18 10 6 2 4 4 3
157 97 70 63 57 89 118 137 163 154 140 157 120
Total Assets 233 232 190 171 122 155 208 223 241 228 222 236 197

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
-12 60 28 7 -4 -4 14 -11 10 12 -9 19
-26 -22 3 1 1 -3 -27 -7 -11 -2 -5 6
37 -39 -29 -10 4 10 14 13 0 10 -2 8
Net Cash Flow -1 -2 2 -1 2 3 0 -5 -0 20 -16 33

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 295 220 188 167 25 48 111 158 252 213 77 78
Inventory Days 54 132 122 94 53 95 65 60 30 97 114 117
Days Payable 180 407 95 106 67 123 153 134 177 128 130 183
Cash Conversion Cycle 170 -55 215 156 12 19 23 85 105 182 61 13
Working Capital Days 201 29 -368 84 59 56 122 187 202 277 222 47
ROCE % 6% 1% -10% -12% -3% 5% 8% -0% 4% 1% 1% -1%

Shareholding Pattern

Numbers in percentages

4 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
41.77% 41.77% 41.77% 42.23% 42.23% 42.23% 42.23% 42.23% 42.23% 37.73% 37.73% 37.73%
0.39% 0.00% 0.04% 0.18% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.29%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 9.16% 6.21%
57.84% 58.23% 58.20% 57.59% 57.77% 57.77% 57.78% 57.78% 57.78% 62.25% 53.10% 53.75%
No. of Shareholders 21,81725,37325,15524,75424,31724,30524,30823,96523,80022,79422,64826,448

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls